H1N1 Seizure Risk in Children Higher Than Seasonal Flu
Author: Wiley-Blackwell
Published: 2010/09/20 - Updated: 2026/02/13
Publication Details: Peer-Reviewed, Research, Study, Analysis
Category Topic: H1N1 Virus - Related Publications
Contents: Synopsis - Introduction - Main - Insights, Updates
Synopsis: This peer-reviewed research, published in Annals of Neurology by University of Utah researchers, presents the most extensive evaluation of neurological complications following H1N1 influenza in pediatric patients. The study analyzed 303 hospitalized children with H1N1 and compared outcomes to 234 children with seasonal flu, revealing that H1N1 caused significantly higher rates of seizures (67%) and encephalopathy (50%) in affected children. Parents, caregivers, and healthcare providers benefit from understanding these findings, as they underscore the importance of flu vaccination in preventing serious neurological complications, particularly for children with underlying medical conditions who face elevated risk. The research provides critical data that helps families and medical professionals recognize warning signs and make informed decisions about preventive care - Disabled World (DW).
Introduction
Higher Rate of Seizures in Children with H1N1
A recent study by researchers at the University of Utah determined that the 2009 pandemic influenza A (H1N1) caused a higher rate of neurological complications in children than the seasonal flu. The most common complications observed were seizures and encephalopathy. Full details of the study, the most extensive evaluation of neurological complications following H1N1 flu in children, are published in the September issue of Annals of Neurology, a journal of the American Neurological Association.
The H1N1 virus (swine flu) was identified in Mexico and the U.S. in April 2009 and quickly spread worldwide, prompting the World Health Organization (WHO) to declare the novel influenza A virus a pandemic. According to estimates from the Centers for Disease Control and Prevention (CDC), 43 million to 89 million Americans were infected with H1N1 between April 2009 and April 10, 2010, with approximately 14 million to 28 million of those cases in children 17 years of age and younger. On August 10, 2010 the WHO International Health Regulations Emergency Committee officially declared an end to the 2009 H1N1 pandemic.
Main Content
In their retrospective study, Josh Bonkowsky, M.D., Ph.D., and colleagues examined neurological complications in children with H1N1 compared to the seasonal flu. Children (younger than 19 years of age) who were hospitalized with H1N1 and neurological complications between April 1 and November 30, 2009 were included in the study. In the comparison group, the research team used records of children hospitalized with seasonal flu and neurological complications from July 1, 2004-June 30, 2008.
Neurological complications observed included seizures, febrile seizures, status epilepticus, encephalopathy, encephalitis, myositis, myalgia, aphasia, ataxia, neuropathy, Guillain-Barre syndrome, or other focal neurological complaints.
Researchers identified 303 children who were hospitalized with 2009 H1N1 of which 18 experienced neurological complications. Eight-three percent of these pediatric patients had an underlying medical condition primarily neurological issues (66%). The research team found the most common neurologic symptoms in this group were seizures (67%) and encephalopathy (50%). More than half of those children who experienced seizures presented in a life-threatening state known as status epilepticus, where continuous seizure activity occurs for more than 5 to 30 minutes.
The comparison group included 234 children who were hospitalized for seasonal flu with 16 patients experiencing neurological issues. In the seasonal flu cohort only 25% patients had underlying medical conditions. The researchers also noted that none of the patients with seasonal flu and neurological complications had encephalopathy, aphasia, or focal neurological deficits.
Compared to seasonal influenza, patients with H1N1 were more likely to have abnormal electroencephalogram (EEG) findings.
"We found that more pediatric H1N1 patients had neurological deficits and required ongoing treatment with anti-epileptic medications upon discharge from the hospital," commented Dr. Bonkowsky.
Additionally, researchers found the use of steroids or intravenous immunoglobulin was not beneficial in the treatment of encephalopathy.
"The absence of proven treatments for influenza-related neurological complications underlines the importance of vaccination," said Dr. Bonkowsky.
For protection against the flu, the CDC recommends yearly flu vaccination and the U.S. 2010-2011 seasonal influenza vaccine will protect against an H3N2 virus, influenza B, and the 2009 H1N1 virus.
This study is published in Annals of Neurology.
Full citation: "Heightened Neurologic Complications in Children with Pandemic H1N1 Influenza." Jeffrey J. Ekstrand, Amy Herbener, Julia Rawlings, Beth Turney, Krow Ampofo, E. Kent Korgenski, Joshua L. Bonkowsky. Annals of Neurology; Published Online: September 20, 2010.
Insights, Analysis, and Developments
Editorial Note: The stark contrast between H1N1 and seasonal flu outcomes revealed in this study - with over half of seizure patients presenting in status epilepticus, a life-threatening condition - reinforces why pandemic influenza strains demand heightened vigilance from both medical professionals and families. While the 2009 H1N1 pandemic has ended, the virus remains part of the seasonal flu landscape, making the study's findings about neurological complications and the absence of effective treatments for encephalopathy particularly relevant today. These results remind us that vaccination remains our most powerful tool against influenza-related complications, especially for children with neurological conditions who face disproportionate risk when infected - Disabled World (DW).Attribution/Source(s): This peer reviewed publication was selected for publishing by the editors of Disabled World (DW) due to its relevance to the disability community. Originally authored by Wiley-Blackwell and published on 2010/09/20, this content may have been edited for style, clarity, or brevity.